Research Interests
Juvenile myositis, lupus, and localized scleroderma. Patient-reported outcomes, mental health, stress, adverse childhood experiences, cardiovascular health, psychometrics, and qualitative/mixed methods research. Novel therapies and clinical trials for pediatric rheumatic diseases.
Selected Grants
Teams Engaged in Accessible Mental Health Interventions for Lupus Erythematosus and Dermatomyositis Stress
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2025 - 2030A Phase 1/2, Open-Label Study to Evaluate the Safety and Efficacy of Autologous CD19-specific Chimeric Antigen Receptor T cells (CABA-201) in Subjects with Active Idiopathic Inflammatory Myopathy or A
Clinical TrialPrincipal Investigator · Awarded by Cabaletta Bio, Inc. · 2025 - 2028Using Bioengineered Human Muscle to Develop Treatments for Juvenile Dermatomyositis
ResearchCollaborator · Awarded by Hartwell Foundation · 2025 - 2028CZI JDM Study Stakeholder Engagement
ResearchPrincipal Investigator · Awarded by Cure JM Foundation · 2024 - 2026Supporting Development of Interventions to Reduce Stress and Promote Cardiovascular Health in Juvenile Lupus and Dermatomyositis
ResearchPrincipal Investigator · Awarded by Rheumatology Research Foundation · 2024 - 2026Preclinical Study of CAR-T Cell Therapy in Juvenile Dermatomyositis
ResearchPrincipal Investigator · Awarded by Cabaletta Bio, Inc. · 2025 - 2026Validation of a Pediatric DOSE Survey to Assess Medication Adherence
ResearchCollaborator · Awarded by Lupus Foundation of America · 2025 - 2026A Phase III, Randomized, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of IV Anifrolumab in Pediatric Participants 5 t
Clinical TrialPrincipal Investigator · Awarded by AstraZeneca AB · 2025 - 2026CARRA Registry REPresentativeness Pilot (CARRA RREP) study
ResearchPrincipal Investigator · Awarded by Indiana University · 2025 - 2026Pediatrics Juvenile Myositis program support
ResearchCo Investigator · Awarded by Cure JM Foundation · 2019 - 2025Patient-Centered Stress Reduction & Cardiovascular Health Promotion Intervention: Engaging Patients with Lupus & Dermatomyositis
ResearchPrincipal Investigator · Awarded by Childhood Arthritis & Rheumatology Research Alliance, Inc. · 2025 - 2025Psychological Stress and Cardiovascular Health in Juvenile Lupus and Dermatomyositis
ResearchPrincipal Investigator · Awarded by Rheumatology Research Foundation · 2021 - 2025Facilitating international, multi-disciplinary collaboration in pediatric localized scleroderma research: International validation of outcome measures
ResearchCo Investigator · Awarded by Childhood Arthritis & Rheumatology Research Alliance, Inc. · 2021 - 2024CARRA Early Investigator Chair Support
ResearchPrincipal Investigator · Awarded by Childhood Arthritis & Rheumatology Research Alliance, Inc. · 2020 - 2023Vamorolone in Juvenile Autoimmune Myositis
Clinical TrialPrincipal Investigator · Awarded by Cure JM Foundation · 2020 - 2022Mental Health Screening in Juvenile Myositis: Pilot and Feasibility Study
ResearchPrincipal Investigator · Awarded by Childhood Arthritis & Rheumatology Research Alliance, Inc. · 2019 - 2022Adverse Childhood Experiences in Juvenile Idiopathic Arthritis
ResearchPrincipal Investigator · Awarded by Albert Einstein College of Medicine · 2019 - 2021CARRA Early Investigator Vice Chair Support
ResearchPrincipal Investigator · Awarded by Childhood Arthritis & Rheumatology Research Alliance, Inc. · 2019 - 2021External Relationships
- American College of Rheumatology
- Cabaletta Bio, Inc
- Childhood Arthritis and Rheumatology Research Alliance
- RheumNow
- Rheumatology Research Foundation
- SingHealth Grant Review Services
- University of Chicago
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.